Emergent BioSolutions
EBS
#6697
Rank
NZ$1.15 B
Marketcap
NZ$21.57
Share price
0.98%
Change (1 day)
50.50%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2025 (TTM): NZ$2.47

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is NZ$2.45. In 2024 the company made an earnings per share (EPS) of NZ-$6.30 an increase over its 2023 EPS that were of NZ-$25.85.

EPS history for Emergent BioSolutions from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$2.47-139.2%
2024NZ-$6.30-75.61%
2023NZ-$25.85232.21%
2022NZ-$7.78-203.46%
2021NZ$7.52-25.09%
2020NZ$10.04445.28%
2019NZ$1.84-15.2%
2018NZ$2.17-35.9%
2017NZ$3.3969.57%
2016NZ$2.00-27.67%
2015NZ$2.7665.63%
2014NZ$1.6711.63%
2013NZ$1.4932.31%
2012NZ$1.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Merck
MRK
NZ$13.19 438.57%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
NZ$0.73-70.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$6.25 155.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
NZ-$5.87-339.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.99 21.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$1.09-55.32%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
NZ-$5.63-329.79%๐Ÿ‡บ๐Ÿ‡ธ USA